The federal government has been releasing a number of policies and proposals that will affect care delivery and are aimed at rising costs of care and prescription drugs.
The federal government has been releasing a number of policies and proposals that will affect care delivery and are aimed at rising costs of care and prescription drugs.
Ted Okon, executive director of the Community Oncology Alliance (COA), sat down with Managed Care Cast to discuss a number of policies affecting COA’s members, including proposals around chimeric antigen receptor T-cell therapies, pharmacy benefit managers, and the Oncology Care Model.
You may need to log in to the website to access this podcast.
Listen above or through one of these podcast services:
CMS Proposes That Patients Be Enrolled in Studies to Get Coverage for CAR T-Cell Therapy
Ted Okon on Policy Priorities for COA in 2019
COA's OCM 2.0: Moving Toward a Universal Payment Model
More Than 300 Groups Seek Halt to CMS' Plans for Global Drug Pricing Index
Trump Proposes Allowing Medicare to Base Drug Prices on What Other Countries Pay
HHS Proposes to End Drug Rebates in Medicare, Medicaid Managed Care
Read more about the stories in this podcast:
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen